Novocure - Novel Therapy for Solid Tumors


William F. Doyle
Executive Chairman

Asaf Danziger
Chief Executive Officer

Gabriel Leung
Vice Chairman, Chair of Global Commercialization Team

Yoram Palti, M.D., Ph.D.
Chief Technology Officer

Wilco Groenhuysen
Chief Financial Officer

Mike Ambrogi
Chief Operating Officer

Eilon Kirson, M.D., Ph.D.
Chief Science Officer and Head of Research and Development

Peter Melnyk
Chief Commercial Officer

Todd Longsworth
General Counsel